Industry Leaders React to Historic Cannabis Rescheduling
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
EDITION:
- EU
- NA
The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive...
Event
Europe’s leading cannabis policy, business and investment conference — bringing senior decision-makers together in Paris.
As the excitement around President Donald Trump's executive order to push forward with cannabis rescheduling has faded, the bill is...
President Donald Trump's executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled...
After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive...
Cannabis Rescheduling fervour has once again reached dramatic levels following media reports that President Donald Trump is considering pushing through...
After a broadly optimistic and reform-driven 2024, this year saw momentum beging to shift once again for the global cannabis...
Just days after announcing a comprehensive rebrand as it shifts its focus to international markets, Organigram Global has acquired Hamilton-based...
Canadian cannabis giant Organigram has officially rebranded as it pivots its strategy towards international operations. The newly dubbed Organigram Global...
London Stock Exchange-listed (LSE) UK medical cannabis operator Kanabo has published its broad financial results for 2024, revealing growing revenue...
British American Tobacco Tobacco giant British American Tobacco (BAT) has announced the launch of a second investment fund as...
Argent BioPharma Argent BioPharma (formerly MGC Pharmaceuticals) has released its latest preliminary financial figures for the year to June...
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
